Investor Relations

DBV Technologies is a global biopharmaceutical company focused on discovering, developing, manufacturing and commercializing treatments for severe allergies

News

DBV Technologies Reports March 31, 2017 Cash Position

Events

2017 BofAML Healthcare Conference

Las Vegas, NV, USA

Documentation

20F- Form 2016

Investor Relations

Phone : +33 1 55 42 78 78
Fax : +33 1 43 26 10 83

Subscribe to get the latest DBV’s News